These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3969319)

  • 21. Clinical and biochemical correlates of growth associated with short-term administration of methionyl growth hormone.
    Kemp SF; Frindik JP; Kearns GL
    Dev Pharmacol Ther; 1993; 20(3-4):199-204. PubMed ID: 7828454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 1 procollagen as a biochemical marker of growth in children with inflammatory bowel disease.
    Hyams JS; Carey DE; Leichtner AM; Goldberg BD
    J Pediatr; 1986 Oct; 109(4):619-24. PubMed ID: 3761075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal assessment of type I procollagen in children with inflammatory bowel disease subjected to surgery.
    Hyams JS; Moore RE; Leichtner AM; Carey DE; Goldberg BD
    J Pediatr Gastroenterol Nutr; 1989 Jan; 8(1):68-74. PubMed ID: 2732865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders.
    Danne T; Grüters A; Schuppan D; Quantas N; Enders I; Weber B
    J Pediatr; 1989 Feb; 114(2):257-60. PubMed ID: 2915284
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth hormone replacement treatment in adult patients.
    Brook CG
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):317. PubMed ID: 8729529
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of serum levels of procollagen propeptides to predict growth velocity.
    Graham MJ
    J Pediatr Gastroenterol Nutr; 1989 Feb; 8(2):143-5. PubMed ID: 2709244
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune function in growth hormone-deficient children treated with biosynthetic growth hormone.
    Etzioni A; Pollack S; Hochberg Z
    Acta Paediatr Scand; 1988 Jan; 77(1):169-70. PubMed ID: 3369299
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.
    Terzolo M; Piovesan A; Osella G; Pia A; Reimondo G; Pozzi C; Raucci C; Torta M; Paccotti P; Angeli A
    Calcif Tissue Int; 1993 Mar; 52(3):188-91. PubMed ID: 8481830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The insulin-like growth factor axis and collagen turnover during prednisolone treatment.
    Wolthers OD; Juul A; Hansen M; Müller J; Pedersen S
    Arch Dis Child; 1994 Nov; 71(5):409-13. PubMed ID: 7529981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagen types I and III propeptides as markers of healing in chronic leg ulcers. A noninvasive method for the determination of procollagen propeptides in wound fluid--influence of growth hormone.
    Rasmussen LH; Jensen LT; Avnstorp C; Karlsmark T; Peters K; Hørslev-Petersen K
    Ann Surg; 1992 Dec; 216(6):684-91. PubMed ID: 1466622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
    Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.
    Cinaz P; Hasanoglu E; Gökçora N; Dogukan S; Demir A
    Mater Med Pol; 1994; 26(2):55-8. PubMed ID: 7745984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunoassay for type I procollagen in growth hormone-deficient children before and during treatment with growth hormone.
    Carey DE; Goldberg B; Ratzan SK; Rubin KR; Rowe DW
    Pediatr Res; 1985 Jan; 19(1):8-11. PubMed ID: 3969319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
    Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
    Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
    Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
    Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
    Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
    Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.